Skip to main content

Table 2 CMR findings

From: Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study

 

Controls (n = 20)

Patients (n = 40)

P

LV-EF (%)

66 ± 4

62 ± 12

0.41

LV-EDV (ml)

109 ± 28

108 ± 36

0.76

LV-ESV (ml)

37 ± 13

41 ± 25

0.86

LV-SV

71 ± 16

66 ± 13

0.41

LV-EDD

45 ± 5

46 ± 5

0.67

LA (cm2)

20 ± 4

20 ± 5

0.68

IVS (mm)

10 ± 2

9 ± 3

0.63

PA (mm)

24 ± 4

24 ± 6

0.56

LV mass (g)

76 ± 18

82 ± 24

0.50

LGE per patient

-

7 (18 %)

 

 Epicardial

-

1 (2 %)

 

 Intramural

-

6 (15 %)

 

 Transmural

-

1 (2 %)

 

 Subendocardial

-

-

 

% LV mass

-

5.3

 

Native T1 (ms)

962 (947–987)

1008 (990–1042)

0.001

Post contrast T1 (ms)

526 (508–553)

494 (477–522)

0.008

ECV (%)

25 (24–27)

28 (26–31)

0.001

T2 (ms)

49 (48–51)

53 (52–58)

<0.001

  1. All values are n or mean ± SD or interquartile ranges
  2. CMR cardiac magnetic resonance, LV left ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume